P
PTC Therapeutics, Inc. (PTCT)
NMS – Real Time Price. Currency in USD
75.02
-1.83 (-2.38%)
At close: May 12, 2026, 4:00 PM EDT
75.02
0.00 (0.00%)
After-hours: May 12, 2026, 4:20 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
75.02
-1.83 (-2.38%)
At close: May 12, 2026, 4:00 PM EDT
75.02
0.00 (0.00%)
After-hours: May 12, 2026, 4:20 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.44 | 6.05 | 10 | |
| Quick ratio | 2.36 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.14 | 1.04 | 8.0 | |
| Interest coverage | 0.94 | -16.91 | 3.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 699M | 938M | 807M | 1.73B | 827M |
| Gross Profit | 538M | 650M | 689M | 1.66B | 732M |
| Operating Income | -440M | -349M | -147M | 857M | -67M |
| Net Income | -559M | -627M | -363M | 683M | -187M |
| EBITDA | -311M | -113M | -71M | 895M | -20M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 53.11 | 108.96 | 10 |
| Next quarter | 31.67 | -42.47 | 5.5 |
| Current year | -36.07 | -99.58 | 1.0 |
| Next year | 14.12 | 5695.19 | 9.0 |
| Weighted average score | 6.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 65.51 | 97.92 | 98.2 | -64.37 | 7.8 |
| Y/Y | -76.82 | -100.31 | -100.29 | -106.93 | 1.0 |
| 3y average | 44.92 | 105.95 | 100.18 | 268.62 | 10 |
| 5y average | 41.19 | 58.32 | 56.76 | 146.99 | 10 |
| Weighted average score | 7.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $834.0M significantly exceed its total debt $395.1M, ensuring strong financial flexibility
Total current assets $2.3B exceed Total current liabilities $923.6M, highlighting excellent liquidity
Debt-to-equity ratio (-2.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (0.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$60.2M limits the company's ability to reinvest or pay down debt